Bi-allelic inactivation of TCF1 in hepatic adenomas
Tóm tắt
Từ khóa
Tài liệu tham khảo
Frain, M. et al. The liver-specific transcription factor LF-B1 contains a highly diverged homeobox DNA binding domain. Cell 59, 145–157 (1989).
Cereghini, S., Yaniv, M. & Cortese, R. Hepatocyte dedifferentiation and extinction is accompanied by a block in the synthesis of mRNA coding for the transcription factor HNF1/LFB1. EMBO J. 9, 2257–2263 (1990).
Yamagata, K. et al. Mutations in the hepatocyte nuclear factor-1α gene in maturity-onset diabetes of the young (MODY3). Nature 384, 455–458 (1996).
Edmondson, H.A., Henderson, B. & Benton, B. Liver-cell adenomas associated with use of oral contraceptives. N. Engl. J. Med. 294, 470–472 (1976).
Sale, G.E. & Lerner, K.G. Multiple tumors after androgen therapy. Arch. Pathol. Lab. Med. 101, 600–603 (1977).
Howell, R.R., Stevenson, R.E., Ben-Menachem, Y., Phyliky, R.L. & Berry, D.H. Hepatic adenomata with type 1 glycogen storage disease. JAMA 236, 1481–1484 (1976).
Flejou, J.F. et al. Liver adenomatosis. An entity distinct from liver adenoma? Gastroenterology 89, 1132–1138 (1985).
Chiche, L. et al. Liver adenomatosis: reappraisal, diagnosis, and surgical management: eight new cases and review of the literature. Ann. Surg. 231, 74–81 (2000).
Goldfarb, S. Sex hormones and hepatic neoplasia. Cancer Res. 36, 2584–2588 (1976).
Ferrell, L.D. Hepatocellular carcinoma arising in a focus of multilobular adenoma. A case report. Am. J. Surg. Pathol. 17, 525–529 (1993).
Baumhueter, S. et al. HNF-1 shares three sequence motifs with the POU domain proteins and is identical to LF-B1 and APF. Genes Dev. 4, 372–379 (1990).
Chouard, T. et al. A distal dimerization domain is essential for DNA-binding by the atypical HNF1 homeodomain. Nucleic Acids Res. 18, 5853–5863 (1990).
Kaisaki, P.J. et al. Mutations in the hepatocyte nuclear factor-1α gene in MODY and early-onset NIDDM: evidence for a mutational hotspot in exon 4. Diabetes 46, 528–535 (1997).
Tsukuma, H. et al. Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N. Engl. J. Med. 328, 1797–1801 (1993).
Nicosia, A. et al. A myosin-like dimerization helix and an extra-large homeodomain are essential elements of the tripartite DNA binding structure of LFB1. Cell 61, 1225–1236 (1990).
Schott, O., Billeter, M., Leiting, B., Wider, G. & Wuthrich, K. The NMR solution structure of the non-classical homeodomain from the rat liver LFB1/HNF1 transcription factor. J. Mol. Biol. 267, 673–683 (1997).
Vaxillaire, M. et al. Anatomy of a homeoprotein revealed by the analysis of human MODY3 mutations. J. Biol. Chem. 274, 35639–35646 (1999).
Ellard, S. Hepatocyte nuclear factor 1α (HNF-1α) mutations in maturity-onset diabetes of the young. Hum. Mutat. 16, 377–385 (2000).
Boland, C.R. et al. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res. 58, 5248–5257 (1998).
Yamagata, K. et al. Mutation P291fsinsC in the transcription factor hepatocyte nuclear factor-1α is dominant negative. Diabetes 47, 1231–1235 (1998).
Collet, C. et al. Prevalence of the missense mutation Gly574Ser in the hepatocyte nuclear factor-1α in Africans with diabetes. Diabetes Metab. 28, 39–44 (2002).
Foster, J.H., Donohue, T.A. & Berman, M.M. Familial liver-cell adenomas and diabetes mellitus. N. Engl. J. Med. 299, 239–241 (1978).
Knudson, A.G. Jr. Mutation and cancer: statistical study of retinoblastoma. Proc. Natl Acad. Sci. USA 68, 820–823 (1971).
Pontoglio, M. et al. Hepatocyte nuclear factor 1 inactivation results in hepatic dysfunction, phenylketonuria, and renal Fanconi syndrome. Cell 84, 575–585 (1996).
Lee, Y.H., Sauer, B. & Gonzalez, F.J. Laron dwarfism and non-insulin-dependent diabetes mellitus in the Hnf-1α knockout mouse. Mol. Cell Biol. 18, 3059–3068 (1998).
Miller, S.A., Dykes, D.D. & Polesky, H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16, 1215 (1988).
Laurent-Puig, P. et al. Genetic alterations associated with hepatocellular carcinomas define distinct pathways of hepatocarcinogenesis. Gastroenterology 120, 1763–1773 (2001).